In early clinical development (CT I), the main target is to deliver the essential amounts of material rapidly and in reproducible top quality.="" in="" accordance="" with="" the="" regulatory="" versatility="" act,="" fda="" has="" regarded="" the="" outcome="" of="" this="" action="" on="" smaller="" companies="" and="" has="" decided="" that="" t